14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ZNTL stock ended at $11.71. This is 5.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.76% from a day low at $11.45 to a day high of $12.11.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Sep 28, 2023 $20.30 $20.91 $19.12 $19.63 1 643 304
Sep 27, 2023 $20.66 $20.83 $19.97 $20.30 434 829
Sep 26, 2023 $20.76 $21.17 $20.26 $20.49 727 044
Sep 25, 2023 $21.15 $21.19 $20.57 $20.75 1 242 258
Sep 22, 2023 $22.13 $22.13 $21.10 $21.27 563 629
Sep 21, 2023 $22.35 $22.70 $21.85 $22.14 539 520
Sep 20, 2023 $22.18 $23.10 $21.81 $22.52 1 533 743
Sep 19, 2023 $22.44 $22.61 $22.04 $22.17 369 322
Sep 18, 2023 $23.30 $23.52 $22.45 $22.49 510 270
Sep 15, 2023 $23.84 $24.97 $23.14 $23.41 1 651 844
Sep 14, 2023 $24.26 $24.27 $23.12 $23.79 954 810
Sep 13, 2023 $24.71 $25.08 $24.18 $24.25 585 308
Sep 12, 2023 $24.85 $25.02 $24.36 $24.70 657 118
Sep 11, 2023 $25.22 $25.33 $24.68 $24.95 383 249
Sep 08, 2023 $24.99 $25.35 $24.57 $25.28 446 415
Sep 07, 2023 $25.09 $25.37 $24.96 $25.04 505 590
Sep 06, 2023 $25.41 $25.81 $24.94 $25.29 417 187
Sep 05, 2023 $27.01 $27.01 $25.36 $25.42 646 621
Sep 01, 2023 $26.69 $27.51 $26.54 $27.14 436 334
Aug 31, 2023 $26.53 $27.09 $26.32 $26.56 490 496
Aug 30, 2023 $25.43 $26.75 $25.26 $26.58 434 864
Aug 29, 2023 $25.50 $25.94 $25.49 $25.59 190 297
Aug 28, 2023 $25.60 $26.00 $25.47 $25.62 188 091
Aug 25, 2023 $25.30 $25.85 $24.97 $25.59 408 578
Aug 24, 2023 $25.75 $26.10 $24.98 $25.22 444 718
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT